Changes to CVS Caremark template formularies effective January 1, 2021 continue our legacy of innovation as well as delivering value and quality care — helping clients save money... More
Purpose-built formulary management and network management strategies from CVS Health are designed to help lower plan costs with minimal member disruption. More
New drugs to treat migraine are approaching approval and could bring relief for many patients, but they portend higher costs. Ongoing monitoring and appropriate utilization... More
Payors can better manage oncology costs by optimizing therapy regimen selection using evidence-based guidelines directly integrated into our proprietary Novologix platform. More
Payors are projected to save on per-member-per-month costs from strategic formulary removals designed to help mitigate the effect of high-cost and hyperinflationary drugs More
Epidiolex, the latest cannabis-based drug to be approved by the FDA to treat certain seizure disorders, is a highly potent form of cannabidiol. Given the narrow indication and... More
New CMS rule enables Medicare Part B Payors to use step therapy to direct patients to lower-cost, clinically appropriate medications first, giving them an opportunity to implement... More